Cardio-Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction

被引:18
作者
Tromp, J. [1 ]
Steggink, L. C. [2 ]
Van Veldhuisen, D. J. [1 ]
Gietema, J. A. [2 ]
van der Meer, P. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands
关键词
ANTHRACYCLINE-INDUCED CARDIOMYOPATHY; CHEMOTHERAPY-INDUCED CARDIOTOXICITY; CELL-DERIVED CARDIOMYOCYTES; BREAST-CANCER; HEART-FAILURE; RISK-FACTOR; DOXORUBICIN THERAPY; CHILDHOOD-CANCER; FOLLOW-UP; TRASTUZUMAB;
D O I
10.1002/cpt.614
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Treatment for cancer has improved in the last decades, resulting in a significantly reduced morbidity and mortality. 1-3 Unfortunately, many systemic treatment options are associated with an increased risk of adverse cardiac effects. 4 These adverse cardiac effects have given rise to the field of cardiooncology. This review summarizes recent findings related to the pathophysiology and treatment of drug-induced cardiac dysfunction in cancer treatment and looks ahead at new developments in the field.
引用
收藏
页码:481 / 490
页数:10
相关论文
共 76 条
[1]   Protective effects of spironolactone against anthracycline-induced cardiomyopathy [J].
Akpek, Mahmut ;
Ozdogru, Ibrahim ;
Sahin, Omer ;
Inanc, Mevlude ;
Dogan, Ali ;
Yazici, Cevat ;
Berk, Veli ;
Karaca, Halit ;
Kalay, Nihat ;
Oguzhan, Abdurrahman ;
Ergin, Ali .
EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (01) :81-89
[2]   Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention [J].
Albini, Adriana ;
Pennesi, Giuseppina ;
Donatelli, Francesco ;
Cammarota, Rosaria ;
De Flora, Silvio ;
Noonan, Douglas M. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (01) :14-25
[3]   Cardiovascular toxicity caused by cancer treatment: strategies for early detection [J].
Altena, Renske ;
Perik, Patrick J. ;
van Veldhuisen, Dirk J. ;
de Vries, Elisabeth G. E. ;
Gietema, Jourik A. .
LANCET ONCOLOGY, 2009, 10 (04) :391-399
[4]   Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation [J].
Armenian, Saro H. ;
Ding, Yan ;
Mills, George ;
Sun, Canlan ;
Venkataraman, Kalyanasundaram ;
Wong, Florence Lennie ;
Neuhausen, Susan L. ;
Senitzer, David ;
Wang, Shirong ;
Forman, Stephen J. ;
Bhatia, Smita .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (02) :205-213
[5]   Screening Adult Survivors of Childhood Cancer for Cardiomyopathy: Comparison of Echocardiography and Cardiac Magnetic Resonance Imaging [J].
Armstrong, Gregory T. ;
Plana, Juan Carlos ;
Zhang, Nan ;
Srivastava, Deokumar ;
Green, Daniel M. ;
Ness, Kirsten K. ;
Donovan, F. Daniel ;
Metzger, Monika L. ;
Arevalo, Alejandro ;
Durand, Jean-Bernard ;
Joshi, Vijaya ;
Hudson, Melissa M. ;
Robison, Leslie L. ;
Flamm, Scott D. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (23) :2876-2884
[6]   Role of the HER2 [lle655Val] genetic polymorphism in tumorogenesis and in the risk of-trastuzumab-related cardiotoxicity [J].
Beauclair, S. ;
Formento, P. ;
Fischel, J. L. ;
Lescaut, W. ;
Largillier, R. ;
Chamorey, E. ;
Hofman, P. ;
Ferrero, J. M. ;
Pages, G. ;
Milano, G. .
ANNALS OF ONCOLOGY, 2007, 18 (08) :1335-1341
[7]   State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: A literature review [J].
Berardi, Rossana ;
Caramanti, Miriam ;
Savini, Agnese ;
Chiorrini, Silvia ;
Pierantoni, Chiara ;
Onofri, Azzurra ;
Ballatore, Zelmira ;
De Lisa, Mariagrazia ;
Mazzanti, Paola ;
Cascinu, Stefano .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 (01) :75-86
[8]   Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes-A Report From the Children's Oncology Group [J].
Blanco, Javier G. ;
Sun, Can-Lan ;
Landier, Wendy ;
Chen, Lu ;
Esparza-Duran, Diego ;
Leisenring, Wendy ;
Mays, Allison ;
Friedman, Debra L. ;
Ginsberg, Jill P. ;
Hudson, Melissa M. ;
Neglia, Joseph P. ;
Oeffinger, Kevin C. ;
Ritchey, A. Kim ;
Villaluna, Doojduen ;
Relling, Mary V. ;
Bhatia, Smita .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (13) :1415-1421
[9]   Angiotensin II-Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial [J].
Boekhout, Annelies H. ;
Gietema, Jourik A. ;
Kerklaan, Bojana Milojkovic ;
van werkhoven, Erik D. ;
Altena, Renske ;
Honkoop, Aafke ;
Los, Maartje ;
Smit, Willem M. ;
Nieboer, Peter ;
Smorenburg, Carolien H. ;
Mandigers, Caroline M. P. W. ;
van der Wouw, Agnes J. ;
Kessels, Lonneke ;
van der Velden, Annette W. G. ;
Ottevanger, Petronella B. ;
Smilde, Tineke ;
de Boer, Jaap ;
van Veldhuisen, Dirk J. ;
Kema, Ido P. ;
de Vries, Elisabeth G. E. ;
Schellens, Jan H. M. .
JAMA ONCOLOGY, 2016, 2 (08) :1030-1037
[10]   Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy for breast cancer in an unselected population [J].
Boerman, L. M. ;
Berendsen, A. J. ;
van der Meer, P. ;
Maduro, J. H. ;
Berger, M. Y. ;
de Bock, G. H. .
SUPPORTIVE CARE IN CANCER, 2014, 22 (07) :1949-1958